Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Novartis Venture Fund

Profile, fund size and portfolio

Parent NovartisHQ Basel, SwitzerlandFounded 1996

Novartis Venture Fund is the corporate venture arm of Novartis, a pharmaceutical and biotech company. It was founded in 1996 and is based in Basel, Switzerland. It invests from seed to Series A. Sectors it names: biotech and life sciences.

AUM or capital under managementS3
USD 750M
Companies backedS1
40+

Every figure links to its source

Snapshot

Investment stage: Seed to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series A
SectorsBiotech and life sciences
GeographyNorth America, Europe
OfficesBasel, Switzerland, Cambridge, United States

Sources: S3 Novartis Venture Fund portfolio; S1 Novartis Venture Fund home.

Graphic 1 of 2

Investment stage: Seed to Series A

Sources: S3 Novartis Venture Fund portfolio; S1 Novartis Venture Fund home.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeUSD 750MAUM or capital under managementStated by the firm or its parentS3
Companies backed40+companiesStated by the firmS1
Companies on the firm's portfolio page31companiesCounted from the firm's own listS3

Sources: S3 Novartis Venture Fund portfolio; S1 Novartis Venture Fund home.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S3 Novartis Venture Fund portfolio; S1 Novartis Venture Fund home.

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Basel, Switzerland
Offices

Investment regionsS3S1

LeadersS2

Novartis Venture Fund on LinkedIn

Key facts

FactValueStatusSource
Parent companyNovartisSingle sourceS8
Parent industryPharmaceuticals and biotechSingle sourceS8
Founded1996Single sourceS4
HeadquartersBasel, SwitzerlandSingle sourceS2
StatusActiveSingle sourceS1
Headline sizeUSD 750M (AUM or capital under management)Single sourceS3
Companies backed40+Single sourceS1
StagesSeed, Series ASingle sourceS3

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

CompanyTypeYearAcquirer or exchangeSource
Acorda TherapeuticsIPO2006NASDAQ: ACORS4
Aeglea BiotherapeuticsIPO2016NASDAQ: AGLES4
Aerpio TherapeuticsIPO2017NASDAQ:ARPOS4
Aileron TherapeuticsIPO2017NASDAQS4
Akebia TherapeuticsIPO2014NASDAQ: AKBAS4
AkouosIPO2020NASDAQ: AKUSS4
Altimmune, Inc.IPO2017NASDAQ: ALTS4
AnnexonIPO2020NASDAQ:ANNXS4
Adicet BioIPO2020NASDAQ: ACETS4
Bicycle TherapeuticsIPO2019NASDAQ: BCYCS4
BioNano GenomicsIPO2018NASDAQ: BNGOS4
CelladonIPO2014NASDAQ: CLDNS4
CellerixIPO2011NYSE: TIGS4
CombinatorRxIPO2005NASDAQ: CRXXS4
Cytos BiotechnologyIPO2002S4
Evolva HoldingIPO2010SIX: EVES4
Forma TherapeuticsIPO2020NASDAQ: FMTXS4
Galera TherapeuticsIPO2019NASDAQ:GRTXS4
Gensight BiologicsIPO2016S4
Idenix PharmaceuticalsIPO2004NASDAQ: IDIXS4

For founders

ItemWhat the firm saysSource
StagesSeed, Series AS3
Check sizeUSD 5M to USD 10MS3

Portfolio

The firm's portfolio page lists 31 companies.S3

The firm also states 40+ companies backed. The page list and the stated total measure different things.S1

Shared portfolio with other corporate VCs

16 companies on the Novartis Venture Fund portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
Pfizer Ventures4FoRx Therapeutics, Mediar Therapeutics, Anaveon, Artios Pharma
JJDC3EpiBiologics, Citryll, ONL Therapeutics
Roche Venture Fund3EpiBiologics, SpliceBio, Vivet Therapeutics
GV2EpiBiologics, RhyGaze
Sanofi Ventures2SpliceBio, Granite Bio
M Ventures2FoRx Therapeutics, NRG Therapeutics
Taiho Ventures1EpiBiologics
UCB Ventures1SpliceBio
Ono Venture Investment1Mediar Therapeutics
3B Future Health Fund1Epsilogen
LG Technology Ventures1Fore Biotherapeutics
Chugai Venture Fund1Hyku Biosciences

Companies backed by the most corporate VCs

Every company on the Novartis Venture Fund list

31 companies, as listed on the firm's own website.S3 Read the firm's list.

  • Amphista Therapeutics
  • Anaveon
  • Aravax
  • Artios Pharma
  • Arvada Therapeutics
  • AstronauTx
  • Atalanta
  • Averna Therapeutics
  • CatalYm
  • Citryll
  • Enterprise Therapeutics
  • Epi Biologics
  • Epsilogen
  • Fore Biotherapeutics
  • FoRx Therapeutics
  • GentiBio
  • Granite Bio
  • HYKU Biosciences
  • Kynexis
  • LoQus23
  • Mediar Therapeutics
  • NRG Therapeutics
  • ONL Therapeutics
  • Protego
  • RhyGaze
  • Salvina
  • Seawolf
  • Sidewinder Therapeutics
  • SpliceBio
  • Tagworks Pharmaceuticals
  • Vivet Therapeutics

History

  1. Novartis Venture Fund founded (IPO exits page: since its foundation in 1996).S4

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Novartis Venture Fund homeFirm
  2. S2Novartis Venture Fund teamFirm
  3. S3Novartis Venture Fund portfolioFirm
  4. S4Novartis Venture Fund IPO exitsFirm
  5. S5Novartis Venture Fund M&A exitsFirm
  6. S8SEC EDGAR submissions: Novartis AG (CIK 1114448)Filing

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Novartis Venture Fund or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.